AN APPROACH TO BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION: A REVIEW

被引:1
|
作者
Arora, Komal [1 ]
Gangadharappa, H. V. [1 ]
机构
[1] JSS Univ, JSS Coll Pharm, Dept Pharmaceut, Pharmaceut Qual Assurance, Mysuru 570015, Karnataka, India
关键词
Matrix; Standards; LLE; SPE; Quality control samples; Bioequivalence; Bioavailability; Validation;
D O I
10.13040/IJPSR.0975-8232.7(6).2291-01
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Bioanalytical method development is the process of creating a procedure to enable a compound of interest to be identified and quantified in a biological matrix. A compound can often be measured by several methods and the choice of analytical method involves many considerations. Analysis of drugs and their metabolites in a biological matrix is carried out using different extraction techniques like liquid-liquid extraction, solid phase extraction (SPE) and protein precipitation from these extraction methods samples are spiked with calibration (reference) standards and using quality control (QC) samples. These methods and choice of analytical method describes the process of method development and includes sampling, sample preparation, separation, detection and evaluation of the results. The developed process is then validated. These bioanalytical validations play a significant role in evaluation and interpretation of bioavailability, bioequivalence, pharmacokinetic, and toxicokinetic studies. In which different parameters like accuracy, precision, selectivity, sensitivity, reproducibility, and stability are performed.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Bioanalytical Method Development and Validation of Griseofulvin Nanoparticles using RP-HPLC
    Muralidharan, Selvadurai
    Venugopal, Vijayan
    Kumar, Jayaraja
    Chiang, Joshua Ho Chen
    Chin, Julin Bee Chu
    Ghan, Siew Chiu
    JOURNAL OF YOUNG PHARMACISTS, 2015, 7 (04) : 384 - 398
  • [32] The development, optimization and validation of an ELISA bioanalytical method for the determination of Cetuximab in human serum
    Hantash, Jamil
    Smidt, Mary
    Bowsher, Ronald R.
    ANALYTICAL METHODS, 2009, 1 (02) : 144 - 148
  • [33] A narrative for bioanalytical method development
    Tremblay, Guy
    BIOANALYSIS, 2017, 9 (03) : 233 - 234
  • [34] Key elements of bioanalytical method validation for macromolecules
    Kelley, Marian
    DeSilva, Binodh
    AAPS JOURNAL, 2007, 9 (02): : E156 - E163
  • [35] Bioanalytical Method Validation—A Revisit with a Decade of Progress
    Vinod P. Shah
    Kamal K. Midha
    John W. A. Findlay
    Howard M. Hill
    James D. Hulse
    Iain J. McGilveray
    Gordon McKay
    Krys J. Miller
    Rabindra N. Patnaik
    Mark L. Powell
    Alfred Tonelli
    C. T. Viswanathan
    Avraham Yacobi
    Pharmaceutical Research, 2000, 17 (12) : 1551 - 1557
  • [36] Recommendations on biomarker bioanalytical method validation by GCC
    Hougton, Richard
    Gouty, Dominique
    Allinson, John
    Green, Rachel
    Losauro, Mike
    Lowes, Steve
    LeLacheurs, Richard
    Garofolo, Fabio
    Couerbe, Philippe
    Bronner, Stephane
    Struwe, Petra
    Schiebl, Christine
    Sangster, Timothy
    Pattison, Colin
    Islam, Rafiq
    Garofolo, Wei
    Pawula, Maria
    Buonarati, Mike
    Hayes, Roger
    Cameron, Mark
    Nicholson, Robert
    Harman, Jake
    Wieling, Jaap
    De Boer, Theo
    Reuschel, Scott
    Cojocaru, Laura
    Harter, Tammy
    Malone, Michele
    Nowatzke, William
    BIOANALYSIS, 2012, 4 (20) : 2439 - 2446
  • [37] Key elements of bioanalytical method validation for macromolecules
    Marian Kelley
    Binodh DeSilva
    The AAPS Journal, 9
  • [38] Quantitative bioanalytical and analytical method development of dibenzazepine derivative, carbamazepine: A review
    Prasanna A.Datar
    JournalofPharmaceuticalAnalysis, 2015, 5 (04) : 213 - 222
  • [39] DEVELOPMENT AND VALIDATION OF A BIOANALYTICAL METHOD FOR THE QUANTIFICATION OF DILTIAZEM AND DESACETYLDILTIAZEM IN PLASMA BY CAPILLARY ZONE ELECTROPHORESIS
    COORS, C
    SCHULZ, HG
    STACHE, F
    JOURNAL OF CHROMATOGRAPHY A, 1995, 717 (1-2) : 235 - 243
  • [40] Development and multicenter validation of an LC-MS-based bioanalytical method for antisense therapeutics
    Sun, Yuchen
    Nitta, Shin-ichiro
    Saito, Kosuke
    Hosogai, Ryuta
    Nakai, Keiko
    Goda, Ryoya
    Shimizu, Hisao
    Fujita, Hisashi
    Kakehi, Masaaki
    Murata, Kazuyuki
    Yamaguchi, Takeru
    Okuzono, Takeshi
    Yamane, Shinichi
    Kawabata, Mitsuhiko
    Matsunuma, Takayuki
    Takahara, Kentaro
    Kato, Noriko
    Yamada, Masaki
    Yoshida, Tokuyuki
    Inoue, Takao
    Saito, Yoshiro
    BIOANALYSIS, 2022, : 1213 - 1227